Kerkar et al. [28] indicated that IL-12 triggers myeloid-derived cells sensitized for tumor destruction, while Eisenring et al. [29] showed that IL-12 induces tumor suppression by stimulating a subset of NKp46+ lymphoid tissue-inducer cells. Here, NCR1 is linked to neoplasm.